Mark R. LaNeve - 11 Apr 2022 Form 3 Insider Report for Charge Enterprises, Inc.

Role: President
Signature: /s/ Mark LaNeve
Issuer symbol: N/A
Transactions as of: 11 Apr 2022
Net transactions value: $0
Form type: 3
Filing time: 11 Apr 2022, 16:01:11 UTC
Previous filing: 14 May 2021
Next filing: 11 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CRGE	Common Stock						250,000	11 Apr 2022	Direct
holding	CRGE	Common Stock						5,000	11 Apr 2022	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CRGE	Options, right to buy							11 Apr 2022	Common Stock	1,000,000	$3.00	Direct	F1
holding	CRGE	Options, right to buy							11 Apr 2022	Common Stock	750,000	$2.80	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On October 28, 2021, the Reporting Person was granted options to purchase 1,000,000 shares of common stock pursuant to the Issuer's 2020 Omnibus Equity Plan. The options vest in installments in the amount of 250,000 shares, with the first installment vesting as of the grant date and the remaining installments vesting on October 28, 2022, October 28, 2023 and October 28, 2024. The options are exercisable for a term of five years.
F2	On June 1, 2021, the Reporting Person was granted options to purchase 750,000 shares of common stock pursuant to the Issuer's 2020 Omnibus Equity Plan. The shares vest annually in equal amounts of 187,500 shares, beginning on June 1, 2022.

Content

On October 28, 2021, the Reporting Person was granted options to purchase 1,000,000 shares of common stock pursuant to the Issuer's 2020 Omnibus Equity Plan. The options vest in installments in the amount of 250,000 shares, with the first installment vesting as of the grant date and the remaining installments vesting on October 28, 2022, October 28, 2023 and October 28, 2024. The options are exercisable for a term of five years.

On June 1, 2021, the Reporting Person was granted options to purchase 750,000 shares of common stock pursuant to the Issuer's 2020 Omnibus Equity Plan. The shares vest annually in equal amounts of 187,500 shares, beginning on June 1, 2022.